nodes	percent_of_prediction	percent_of_DWPC	metapath
Clindamycin—CYP3A4—Thiotepa—urinary bladder cancer	0.197	0.687	CbGbCtD
Clindamycin—CYP3A4—Etoposide—urinary bladder cancer	0.0535	0.186	CbGbCtD
Clindamycin—CYP3A4—Doxorubicin—urinary bladder cancer	0.0365	0.127	CbGbCtD
Clindamycin—Anaemia—Cisplatin—urinary bladder cancer	0.00101	0.00142	CcSEcCtD
Clindamycin—Dyspepsia—Thiotepa—urinary bladder cancer	0.001	0.00141	CcSEcCtD
Clindamycin—Thrombophlebitis—Doxorubicin—urinary bladder cancer	0.000999	0.0014	CcSEcCtD
Clindamycin—Dermatitis exfoliative—Epirubicin—urinary bladder cancer	0.00099	0.00139	CcSEcCtD
Clindamycin—Discomfort—Gemcitabine—urinary bladder cancer	0.000989	0.00139	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000985	0.00138	CcSEcCtD
Clindamycin—Fatigue—Thiotepa—urinary bladder cancer	0.000983	0.00138	CcSEcCtD
Clindamycin—Dysgeusia—Etoposide—urinary bladder cancer	0.000983	0.00138	CcSEcCtD
Clindamycin—Leukopenia—Cisplatin—urinary bladder cancer	0.000981	0.00138	CcSEcCtD
Clindamycin—Dermatitis bullous—Epirubicin—urinary bladder cancer	0.000978	0.00137	CcSEcCtD
Clindamycin—Pain—Thiotepa—urinary bladder cancer	0.000975	0.00137	CcSEcCtD
Clindamycin—Constipation—Thiotepa—urinary bladder cancer	0.000975	0.00137	CcSEcCtD
Clindamycin—Discomfort—Fluorouracil—urinary bladder cancer	0.000972	0.00136	CcSEcCtD
Clindamycin—Back pain—Etoposide—urinary bladder cancer	0.000971	0.00136	CcSEcCtD
Clindamycin—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.000965	0.00135	CcSEcCtD
Clindamycin—Muscle spasms—Etoposide—urinary bladder cancer	0.000965	0.00135	CcSEcCtD
Clindamycin—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000959	0.00135	CcSEcCtD
Clindamycin—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000943	0.00132	CcSEcCtD
Clindamycin—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000939	0.00132	CcSEcCtD
Clindamycin—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000933	0.00131	CcSEcCtD
Clindamycin—Anaemia—Etoposide—urinary bladder cancer	0.000928	0.0013	CcSEcCtD
Clindamycin—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000924	0.0013	CcSEcCtD
Clindamycin—Discomfort—Cisplatin—urinary bladder cancer	0.000922	0.00129	CcSEcCtD
Clindamycin—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.000916	0.00129	CcSEcCtD
Clindamycin—Urticaria—Thiotepa—urinary bladder cancer	0.000906	0.00127	CcSEcCtD
Clindamycin—Dermatitis bullous—Doxorubicin—urinary bladder cancer	0.000905	0.00127	CcSEcCtD
Clindamycin—Vertigo—Etoposide—urinary bladder cancer	0.000902	0.00127	CcSEcCtD
Clindamycin—Body temperature increased—Thiotepa—urinary bladder cancer	0.000902	0.00126	CcSEcCtD
Clindamycin—Abdominal pain—Thiotepa—urinary bladder cancer	0.000902	0.00126	CcSEcCtD
Clindamycin—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.000899	0.00126	CcSEcCtD
Clindamycin—Leukopenia—Etoposide—urinary bladder cancer	0.000899	0.00126	CcSEcCtD
Clindamycin—Hypotension—Gemcitabine—urinary bladder cancer	0.000897	0.00126	CcSEcCtD
Clindamycin—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000894	0.00125	CcSEcCtD
Clindamycin—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.000893	0.00125	CcSEcCtD
Clindamycin—Cardiac arrest—Epirubicin—urinary bladder cancer	0.000888	0.00125	CcSEcCtD
Clindamycin—Hypotension—Fluorouracil—urinary bladder cancer	0.000881	0.00124	CcSEcCtD
Clindamycin—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000876	0.00123	CcSEcCtD
Clindamycin—Hypertension—Etoposide—urinary bladder cancer	0.000867	0.00122	CcSEcCtD
Clindamycin—Dry skin—Epirubicin—urinary bladder cancer	0.000856	0.0012	CcSEcCtD
Clindamycin—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000855	0.0012	CcSEcCtD
Clindamycin—Eosinophilia—Methotrexate—urinary bladder cancer	0.000854	0.0012	CcSEcCtD
Clindamycin—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.000853	0.0012	CcSEcCtD
Clindamycin—Discomfort—Etoposide—urinary bladder cancer	0.000844	0.00118	CcSEcCtD
Clindamycin—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.000841	0.00118	CcSEcCtD
Clindamycin—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000841	0.00118	CcSEcCtD
Clindamycin—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00084	0.00118	CcSEcCtD
Clindamycin—Hypotension—Cisplatin—urinary bladder cancer	0.000836	0.00117	CcSEcCtD
Clindamycin—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00083	0.00116	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000828	0.00116	CcSEcCtD
Clindamycin—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.000827	0.00116	CcSEcCtD
Clindamycin—Fatigue—Gemcitabine—urinary bladder cancer	0.000827	0.00116	CcSEcCtD
Clindamycin—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.000822	0.00115	CcSEcCtD
Clindamycin—Pain—Gemcitabine—urinary bladder cancer	0.00082	0.00115	CcSEcCtD
Clindamycin—Constipation—Gemcitabine—urinary bladder cancer	0.00082	0.00115	CcSEcCtD
Clindamycin—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000819	0.00115	CcSEcCtD
Clindamycin—Asthenia—Thiotepa—urinary bladder cancer	0.000818	0.00115	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000814	0.00114	CcSEcCtD
Clindamycin—Abdominal distension—Epirubicin—urinary bladder cancer	0.000813	0.00114	CcSEcCtD
Clindamycin—Dysuria—Methotrexate—urinary bladder cancer	0.000807	0.00113	CcSEcCtD
Clindamycin—Neutropenia—Methotrexate—urinary bladder cancer	0.000807	0.00113	CcSEcCtD
Clindamycin—Pruritus—Thiotepa—urinary bladder cancer	0.000807	0.00113	CcSEcCtD
Clindamycin—Pain—Fluorouracil—urinary bladder cancer	0.000807	0.00113	CcSEcCtD
Clindamycin—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000802	0.00113	CcSEcCtD
Clindamycin—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.000802	0.00113	CcSEcCtD
Clindamycin—Eosinophilia—Epirubicin—urinary bladder cancer	0.0008	0.00112	CcSEcCtD
Clindamycin—Dyspnoea—Cisplatin—urinary bladder cancer	0.000797	0.00112	CcSEcCtD
Clindamycin—Dry skin—Doxorubicin—urinary bladder cancer	0.000792	0.00111	CcSEcCtD
Clindamycin—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.00079	0.00111	CcSEcCtD
Clindamycin—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000788	0.00111	CcSEcCtD
Clindamycin—Diarrhoea—Thiotepa—urinary bladder cancer	0.00078	0.00109	CcSEcCtD
Clindamycin—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.000779	0.00109	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000772	0.00108	CcSEcCtD
Clindamycin—Hypotension—Etoposide—urinary bladder cancer	0.000766	0.00107	CcSEcCtD
Clindamycin—Pain—Cisplatin—urinary bladder cancer	0.000765	0.00107	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000763	0.00107	CcSEcCtD
Clindamycin—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000758	0.00106	CcSEcCtD
Clindamycin—Neutropenia—Epirubicin—urinary bladder cancer	0.000755	0.00106	CcSEcCtD
Clindamycin—Dysuria—Epirubicin—urinary bladder cancer	0.000755	0.00106	CcSEcCtD
Clindamycin—Dizziness—Thiotepa—urinary bladder cancer	0.000754	0.00106	CcSEcCtD
Clindamycin—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000752	0.00106	CcSEcCtD
Clindamycin—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.000751	0.00105	CcSEcCtD
Clindamycin—Urticaria—Fluorouracil—urinary bladder cancer	0.000749	0.00105	CcSEcCtD
Clindamycin—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000746	0.00105	CcSEcCtD
Clindamycin—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00074	0.00104	CcSEcCtD
Clindamycin—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000737	0.00103	CcSEcCtD
Clindamycin—Dyspnoea—Etoposide—urinary bladder cancer	0.00073	0.00102	CcSEcCtD
Clindamycin—Epistaxis—Methotrexate—urinary bladder cancer	0.000726	0.00102	CcSEcCtD
Clindamycin—Vomiting—Thiotepa—urinary bladder cancer	0.000725	0.00102	CcSEcCtD
Clindamycin—Rash—Thiotepa—urinary bladder cancer	0.000719	0.00101	CcSEcCtD
Clindamycin—Dermatitis—Thiotepa—urinary bladder cancer	0.000718	0.00101	CcSEcCtD
Clindamycin—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000718	0.00101	CcSEcCtD
Clindamycin—Headache—Thiotepa—urinary bladder cancer	0.000715	0.001	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000714	0.001	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000707	0.000992	CcSEcCtD
Clindamycin—Body temperature increased—Cisplatin—urinary bladder cancer	0.000707	0.000992	CcSEcCtD
Clindamycin—Fatigue—Etoposide—urinary bladder cancer	0.000706	0.000991	CcSEcCtD
Clindamycin—Jaundice—Epirubicin—urinary bladder cancer	0.000702	0.000985	CcSEcCtD
Clindamycin—Constipation—Etoposide—urinary bladder cancer	0.000701	0.000983	CcSEcCtD
Clindamycin—Pain—Etoposide—urinary bladder cancer	0.000701	0.000983	CcSEcCtD
Clindamycin—Urinary tract infection—Epirubicin—urinary bladder cancer	0.0007	0.000982	CcSEcCtD
Clindamycin—Dysuria—Doxorubicin—urinary bladder cancer	0.000699	0.00098	CcSEcCtD
Clindamycin—Neutropenia—Doxorubicin—urinary bladder cancer	0.000699	0.00098	CcSEcCtD
Clindamycin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000695	0.000975	CcSEcCtD
Clindamycin—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000694	0.000974	CcSEcCtD
Clindamycin—Asthenia—Gemcitabine—urinary bladder cancer	0.000688	0.000966	CcSEcCtD
Clindamycin—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000682	0.000957	CcSEcCtD
Clindamycin—Epistaxis—Epirubicin—urinary bladder cancer	0.000679	0.000953	CcSEcCtD
Clindamycin—Pruritus—Gemcitabine—urinary bladder cancer	0.000679	0.000952	CcSEcCtD
Clindamycin—Nausea—Thiotepa—urinary bladder cancer	0.000677	0.00095	CcSEcCtD
Clindamycin—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000672	0.000943	CcSEcCtD
Clindamycin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00067	0.00094	CcSEcCtD
Clindamycin—Pruritus—Fluorouracil—urinary bladder cancer	0.000667	0.000936	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000661	0.000927	CcSEcCtD
Clindamycin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000659	0.000924	CcSEcCtD
Clindamycin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000656	0.000921	CcSEcCtD
Clindamycin—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000653	0.000916	CcSEcCtD
Clindamycin—Urticaria—Etoposide—urinary bladder cancer	0.000651	0.000913	CcSEcCtD
Clindamycin—Jaundice—Doxorubicin—urinary bladder cancer	0.000649	0.000911	CcSEcCtD
Clindamycin—Abdominal pain—Etoposide—urinary bladder cancer	0.000648	0.000909	CcSEcCtD
Clindamycin—Body temperature increased—Etoposide—urinary bladder cancer	0.000648	0.000909	CcSEcCtD
Clindamycin—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000648	0.000909	CcSEcCtD
Clindamycin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000645	0.000905	CcSEcCtD
Clindamycin—Asthenia—Cisplatin—urinary bladder cancer	0.000642	0.0009	CcSEcCtD
Clindamycin—Epistaxis—Doxorubicin—urinary bladder cancer	0.000628	0.000882	CcSEcCtD
Clindamycin—Dizziness—Fluorouracil—urinary bladder cancer	0.000624	0.000875	CcSEcCtD
Clindamycin—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000622	0.000872	CcSEcCtD
Clindamycin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000612	0.000858	CcSEcCtD
Clindamycin—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000611	0.000857	CcSEcCtD
Clindamycin—Vomiting—Gemcitabine—urinary bladder cancer	0.00061	0.000856	CcSEcCtD
Clindamycin—Rash—Gemcitabine—urinary bladder cancer	0.000605	0.000849	CcSEcCtD
Clindamycin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000604	0.000848	CcSEcCtD
Clindamycin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000604	0.000847	CcSEcCtD
Clindamycin—Erythema—Methotrexate—urinary bladder cancer	0.000601	0.000844	CcSEcCtD
Clindamycin—Headache—Gemcitabine—urinary bladder cancer	0.000601	0.000843	CcSEcCtD
Clindamycin—Flushing—Epirubicin—urinary bladder cancer	0.0006	0.000842	CcSEcCtD
Clindamycin—Vomiting—Fluorouracil—urinary bladder cancer	0.0006	0.000841	CcSEcCtD
Clindamycin—Rash—Fluorouracil—urinary bladder cancer	0.000595	0.000834	CcSEcCtD
Clindamycin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000594	0.000834	CcSEcCtD
Clindamycin—Headache—Fluorouracil—urinary bladder cancer	0.000591	0.000829	CcSEcCtD
Clindamycin—Dysgeusia—Methotrexate—urinary bladder cancer	0.000589	0.000826	CcSEcCtD
Clindamycin—Asthenia—Etoposide—urinary bladder cancer	0.000588	0.000825	CcSEcCtD
Clindamycin—Back pain—Methotrexate—urinary bladder cancer	0.000582	0.000816	CcSEcCtD
Clindamycin—Pruritus—Etoposide—urinary bladder cancer	0.00058	0.000813	CcSEcCtD
Clindamycin—Nausea—Gemcitabine—urinary bladder cancer	0.00057	0.000799	CcSEcCtD
Clindamycin—Vomiting—Cisplatin—urinary bladder cancer	0.000569	0.000798	CcSEcCtD
Clindamycin—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000566	0.000793	CcSEcCtD
Clindamycin—Rash—Cisplatin—urinary bladder cancer	0.000564	0.000791	CcSEcCtD
Clindamycin—Dermatitis—Cisplatin—urinary bladder cancer	0.000563	0.00079	CcSEcCtD
Clindamycin—Erythema—Epirubicin—urinary bladder cancer	0.000563	0.000789	CcSEcCtD
Clindamycin—Diarrhoea—Etoposide—urinary bladder cancer	0.000561	0.000786	CcSEcCtD
Clindamycin—Nausea—Fluorouracil—urinary bladder cancer	0.00056	0.000786	CcSEcCtD
Clindamycin—Anaemia—Methotrexate—urinary bladder cancer	0.000556	0.00078	CcSEcCtD
Clindamycin—Flushing—Doxorubicin—urinary bladder cancer	0.000555	0.000779	CcSEcCtD
Clindamycin—Flatulence—Epirubicin—urinary bladder cancer	0.000554	0.000778	CcSEcCtD
Clindamycin—Dysgeusia—Epirubicin—urinary bladder cancer	0.000551	0.000773	CcSEcCtD
Clindamycin—Back pain—Epirubicin—urinary bladder cancer	0.000544	0.000764	CcSEcCtD
Clindamycin—Dizziness—Etoposide—urinary bladder cancer	0.000542	0.00076	CcSEcCtD
Clindamycin—Muscle spasms—Epirubicin—urinary bladder cancer	0.000541	0.000759	CcSEcCtD
Clindamycin—Vertigo—Methotrexate—urinary bladder cancer	0.00054	0.000758	CcSEcCtD
Clindamycin—Leukopenia—Methotrexate—urinary bladder cancer	0.000538	0.000755	CcSEcCtD
Clindamycin—Nausea—Cisplatin—urinary bladder cancer	0.000531	0.000745	CcSEcCtD
Clindamycin—Vomiting—Etoposide—urinary bladder cancer	0.000521	0.000731	CcSEcCtD
Clindamycin—Erythema—Doxorubicin—urinary bladder cancer	0.000521	0.00073	CcSEcCtD
Clindamycin—Anaemia—Epirubicin—urinary bladder cancer	0.00052	0.00073	CcSEcCtD
Clindamycin—Rash—Etoposide—urinary bladder cancer	0.000517	0.000725	CcSEcCtD
Clindamycin—Dermatitis—Etoposide—urinary bladder cancer	0.000516	0.000724	CcSEcCtD
Clindamycin—Headache—Etoposide—urinary bladder cancer	0.000513	0.00072	CcSEcCtD
Clindamycin—Flatulence—Doxorubicin—urinary bladder cancer	0.000513	0.00072	CcSEcCtD
Clindamycin—Dysgeusia—Doxorubicin—urinary bladder cancer	0.00051	0.000715	CcSEcCtD
Clindamycin—Discomfort—Methotrexate—urinary bladder cancer	0.000506	0.00071	CcSEcCtD
Clindamycin—Vertigo—Epirubicin—urinary bladder cancer	0.000506	0.000709	CcSEcCtD
Clindamycin—Leukopenia—Epirubicin—urinary bladder cancer	0.000504	0.000707	CcSEcCtD
Clindamycin—Back pain—Doxorubicin—urinary bladder cancer	0.000504	0.000707	CcSEcCtD
Clindamycin—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000501	0.000702	CcSEcCtD
Clindamycin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000491	0.000688	CcSEcCtD
Clindamycin—Nausea—Etoposide—urinary bladder cancer	0.000487	0.000683	CcSEcCtD
Clindamycin—Hypertension—Epirubicin—urinary bladder cancer	0.000486	0.000682	CcSEcCtD
Clindamycin—Anaemia—Doxorubicin—urinary bladder cancer	0.000481	0.000675	CcSEcCtD
Clindamycin—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00048	0.000674	CcSEcCtD
Clindamycin—Discomfort—Epirubicin—urinary bladder cancer	0.000473	0.000664	CcSEcCtD
Clindamycin—Vertigo—Doxorubicin—urinary bladder cancer	0.000468	0.000656	CcSEcCtD
Clindamycin—Leukopenia—Doxorubicin—urinary bladder cancer	0.000466	0.000654	CcSEcCtD
Clindamycin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000459	0.000644	CcSEcCtD
Clindamycin—Hypotension—Methotrexate—urinary bladder cancer	0.000459	0.000643	CcSEcCtD
Clindamycin—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.00045	0.000631	CcSEcCtD
Clindamycin—Hypertension—Doxorubicin—urinary bladder cancer	0.00045	0.000631	CcSEcCtD
Clindamycin—Discomfort—Doxorubicin—urinary bladder cancer	0.000438	0.000614	CcSEcCtD
Clindamycin—Dyspnoea—Methotrexate—urinary bladder cancer	0.000438	0.000614	CcSEcCtD
Clindamycin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000432	0.000606	CcSEcCtD
Clindamycin—Hypotension—Epirubicin—urinary bladder cancer	0.000429	0.000602	CcSEcCtD
Clindamycin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000425	0.000596	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000424	0.000594	CcSEcCtD
Clindamycin—Fatigue—Methotrexate—urinary bladder cancer	0.000423	0.000594	CcSEcCtD
Clindamycin—Pain—Methotrexate—urinary bladder cancer	0.00042	0.000589	CcSEcCtD
Clindamycin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000416	0.000584	CcSEcCtD
Clindamycin—Dyspnoea—Epirubicin—urinary bladder cancer	0.000409	0.000574	CcSEcCtD
Clindamycin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000404	0.000567	CcSEcCtD
Clindamycin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000401	0.000563	CcSEcCtD
Clindamycin—Hypotension—Doxorubicin—urinary bladder cancer	0.000397	0.000557	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000396	0.000556	CcSEcCtD
Clindamycin—Fatigue—Epirubicin—urinary bladder cancer	0.000396	0.000555	CcSEcCtD
Clindamycin—Constipation—Epirubicin—urinary bladder cancer	0.000393	0.000551	CcSEcCtD
Clindamycin—Pain—Epirubicin—urinary bladder cancer	0.000393	0.000551	CcSEcCtD
Clindamycin—Urticaria—Methotrexate—urinary bladder cancer	0.00039	0.000547	CcSEcCtD
Clindamycin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000388	0.000544	CcSEcCtD
Clindamycin—Body temperature increased—Methotrexate—urinary bladder cancer	0.000388	0.000544	CcSEcCtD
Clindamycin—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000379	0.000531	CcSEcCtD
Clindamycin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000376	0.000527	CcSEcCtD
Clindamycin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000374	0.000525	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000367	0.000515	CcSEcCtD
Clindamycin—Fatigue—Doxorubicin—urinary bladder cancer	0.000366	0.000514	CcSEcCtD
Clindamycin—Urticaria—Epirubicin—urinary bladder cancer	0.000365	0.000512	CcSEcCtD
Clindamycin—Constipation—Doxorubicin—urinary bladder cancer	0.000363	0.00051	CcSEcCtD
Clindamycin—Pain—Doxorubicin—urinary bladder cancer	0.000363	0.00051	CcSEcCtD
Clindamycin—Body temperature increased—Epirubicin—urinary bladder cancer	0.000363	0.000509	CcSEcCtD
Clindamycin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000363	0.000509	CcSEcCtD
Clindamycin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000362	0.000507	CcSEcCtD
Clindamycin—Asthenia—Methotrexate—urinary bladder cancer	0.000352	0.000494	CcSEcCtD
Clindamycin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000347	0.000487	CcSEcCtD
Clindamycin—Pruritus—Methotrexate—urinary bladder cancer	0.000347	0.000487	CcSEcCtD
Clindamycin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000338	0.000475	CcSEcCtD
Clindamycin—Urticaria—Doxorubicin—urinary bladder cancer	0.000338	0.000474	CcSEcCtD
Clindamycin—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000336	0.000471	CcSEcCtD
Clindamycin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000336	0.000471	CcSEcCtD
Clindamycin—Diarrhoea—Methotrexate—urinary bladder cancer	0.000336	0.000471	CcSEcCtD
Clindamycin—Asthenia—Epirubicin—urinary bladder cancer	0.00033	0.000462	CcSEcCtD
Clindamycin—Pruritus—Epirubicin—urinary bladder cancer	0.000325	0.000456	CcSEcCtD
Clindamycin—Dizziness—Methotrexate—urinary bladder cancer	0.000325	0.000455	CcSEcCtD
Clindamycin—Diarrhoea—Epirubicin—urinary bladder cancer	0.000314	0.000441	CcSEcCtD
Clindamycin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000313	0.000439	CcSEcCtD
Clindamycin—Vomiting—Methotrexate—urinary bladder cancer	0.000312	0.000438	CcSEcCtD
Clindamycin—Rash—Methotrexate—urinary bladder cancer	0.000309	0.000434	CcSEcCtD
Clindamycin—Dermatitis—Methotrexate—urinary bladder cancer	0.000309	0.000434	CcSEcCtD
Clindamycin—Headache—Methotrexate—urinary bladder cancer	0.000307	0.000431	CcSEcCtD
Clindamycin—Asthenia—Doxorubicin—urinary bladder cancer	0.000305	0.000428	CcSEcCtD
Clindamycin—Dizziness—Epirubicin—urinary bladder cancer	0.000304	0.000426	CcSEcCtD
Clindamycin—Pruritus—Doxorubicin—urinary bladder cancer	0.000301	0.000422	CcSEcCtD
Clindamycin—Vomiting—Epirubicin—urinary bladder cancer	0.000292	0.00041	CcSEcCtD
Clindamycin—Nausea—Methotrexate—urinary bladder cancer	0.000291	0.000409	CcSEcCtD
Clindamycin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000291	0.000408	CcSEcCtD
Clindamycin—Rash—Epirubicin—urinary bladder cancer	0.00029	0.000406	CcSEcCtD
Clindamycin—Dermatitis—Epirubicin—urinary bladder cancer	0.000289	0.000406	CcSEcCtD
Clindamycin—Headache—Epirubicin—urinary bladder cancer	0.000288	0.000404	CcSEcCtD
Clindamycin—Dizziness—Doxorubicin—urinary bladder cancer	0.000281	0.000394	CcSEcCtD
Clindamycin—Nausea—Epirubicin—urinary bladder cancer	0.000273	0.000383	CcSEcCtD
Clindamycin—Vomiting—Doxorubicin—urinary bladder cancer	0.00027	0.000379	CcSEcCtD
Clindamycin—Rash—Doxorubicin—urinary bladder cancer	0.000268	0.000376	CcSEcCtD
Clindamycin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000268	0.000376	CcSEcCtD
Clindamycin—Headache—Doxorubicin—urinary bladder cancer	0.000266	0.000373	CcSEcCtD
Clindamycin—Nausea—Doxorubicin—urinary bladder cancer	0.000252	0.000354	CcSEcCtD
